Biopharmaceutical production scrap consists of different polymers, multi-layer films and some hazardous materials. A recycling program is demonstrating that this tough-to-tackle stream doesn’t have to be destined for disposal.
Global biopharmaceutical products supplier MilliporeSigma has partnered with specialty waste management company Triumvirate Environmental to recycle the commingled single-use plastic scrap into saleable lumber products.
Single-use plastic is on the rise in the life science industry—making it increasingly important to change the end-of-life scenario for products, which often end up in landfills or are incinerated. MilliporeSigma continues to tackle this issue through its unique, industry-first recycling programs operated in partnership with Triumvirate Environmental—taking big steps toward smaller footprints.
Wrapping up our bioprocessing category is MilliporeSigma’s Biopharma Product Recycling Program. The increase in single-use plastics waste is pushing biopharma manufacturers to address the environmental impact of currently utilized methods of disposal, such as landfilling and incineration, and question whether there is a better option.
As single-use technology becomes mainstream, biopharma companies need a better way to handle waste
MilliporeSigma estimates that a single biopharma site produces about 12.5 tons waste per month that is eligible for recycling. As a leading supplier of single-use biopharmaceutical products, including single-use bags, tubing, connectors and filters, MilliporeSigma recognizes the need to reduce the environmental impact of its products.
In 2015, MilliporeSigma launched an exclusive partnership with Triumvirate Environmental in order to enable bioprocess manufacturing customers to fully recycle plastic single-use and disposable products.
It is well known that single-use systems provide a variety of benefits to drug manufacturers, but the growth of single-use brings to mind the environmental impact that comes with this trend. Globally, we estimate that 30,000 tons of biopharma single-use products are disposed to landfill or incineration every year. Single-use systems are made primarily of plastic, and I think most people agree that plastic consumption should be reduced and recycling increased. In fact, the plastic used in single-use technologies is of excellent quality because it has limited or no additives.
Here at Triumvirate Environmental, we work with our partners in environmental, health, and safety to promote environmental protection and sustainable development. Today, we would like to focus on one of our life sciences partners who has gone above and beyond to put a focus on corporate responsibility and recycling, MilliporeSigma. Read below to learn all about MilliporeSigma, single-use technologies, and their role in biopharma recycling.